nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—CYP3A4—type 2 diabetes mellitus	0.27	1	CbGaD
Olopatadine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0418	0.152	CbGbCtD
Olopatadine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.0372	0.136	CbGbCtD
Olopatadine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0341	0.124	CbGbCtD
Olopatadine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.0298	0.109	CbGbCtD
Olopatadine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0269	0.0982	CbGbCtD
Olopatadine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.0204	0.0744	CbGbCtD
Olopatadine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.0196	0.0714	CbGbCtD
Olopatadine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.0196	0.0714	CbGbCtD
Olopatadine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.0185	0.0675	CbGbCtD
Olopatadine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.0138	0.0503	CbGbCtD
Olopatadine—CYP3A4—Losartan—type 2 diabetes mellitus	0.0126	0.046	CbGbCtD
Olopatadine—S100B—peripheral nervous system—type 2 diabetes mellitus	0.0118	0.121	CbGeAlD
Olopatadine—S100B—artery—type 2 diabetes mellitus	0.00924	0.0948	CbGeAlD
Olopatadine—S100B—nerve—type 2 diabetes mellitus	0.00917	0.094	CbGeAlD
Olopatadine—S100A2—islet of Langerhans—type 2 diabetes mellitus	0.00558	0.0572	CbGeAlD
Olopatadine—S100A2—nephron tubule—type 2 diabetes mellitus	0.00449	0.0461	CbGeAlD
Olopatadine—S100A1—nephron tubule—type 2 diabetes mellitus	0.00414	0.0424	CbGeAlD
Olopatadine—S100A2—pancreas—type 2 diabetes mellitus	0.00392	0.0402	CbGeAlD
Olopatadine—S100A2—cortex of kidney—type 2 diabetes mellitus	0.00385	0.0394	CbGeAlD
Olopatadine—S100B—retina—type 2 diabetes mellitus	0.0038	0.0389	CbGeAlD
Olopatadine—S100A1—cardiovascular system—type 2 diabetes mellitus	0.00372	0.0381	CbGeAlD
Olopatadine—S100A1—kidney—type 2 diabetes mellitus	0.00364	0.0373	CbGeAlD
Olopatadine—S100A2—adipose tissue—type 2 diabetes mellitus	0.00356	0.0365	CbGeAlD
Olopatadine—S100A1—cortex of kidney—type 2 diabetes mellitus	0.00354	0.0363	CbGeAlD
Olopatadine—S100A13—Methylergometrine—Bromocriptine—type 2 diabetes mellitus	0.00345	0.724	CbGdCrCtD
Olopatadine—S100A13—cardiovascular system—type 2 diabetes mellitus	0.0033	0.0338	CbGeAlD
Olopatadine—S100A1—adipose tissue—type 2 diabetes mellitus	0.00328	0.0336	CbGeAlD
Olopatadine—S100A12—cardiovascular system—type 2 diabetes mellitus	0.00325	0.0334	CbGeAlD
Olopatadine—S100B—cardiovascular system—type 2 diabetes mellitus	0.00321	0.0329	CbGeAlD
Olopatadine—S100A13—adipose tissue—type 2 diabetes mellitus	0.00291	0.0298	CbGeAlD
Olopatadine—S100A12—adipose tissue—type 2 diabetes mellitus	0.00287	0.0294	CbGeAlD
Olopatadine—S100B—adipose tissue—type 2 diabetes mellitus	0.00283	0.029	CbGeAlD
Olopatadine—S100A13—liver—type 2 diabetes mellitus	0.00204	0.0209	CbGeAlD
Olopatadine—S100A12—liver—type 2 diabetes mellitus	0.00201	0.0206	CbGeAlD
Olopatadine—S100A13—Bortezomib—Nateglinide—type 2 diabetes mellitus	0.00131	0.276	CbGdCrCtD
Olopatadine—HRH1—adipose tissue—type 2 diabetes mellitus	0.000581	0.00596	CbGeAlD
Olopatadine—CYP3A4—kidney—type 2 diabetes mellitus	0.000498	0.00511	CbGeAlD
Olopatadine—Cyclobenzaprine—CYP1A2—type 2 diabetes mellitus	0.000332	0.0614	CrCbGaD
Olopatadine—Thiothixene—ADRA2A—type 2 diabetes mellitus	0.000318	0.0588	CrCbGaD
Olopatadine—CYP3A4—liver—type 2 diabetes mellitus	0.000315	0.00323	CbGeAlD
Olopatadine—Thiothixene—HTR2C—type 2 diabetes mellitus	0.000293	0.0541	CrCbGaD
Olopatadine—Infection—Gliclazide—type 2 diabetes mellitus	0.000273	0.00121	CcSEcCtD
Olopatadine—Dyspnoea—Glyburide—type 2 diabetes mellitus	0.000272	0.00121	CcSEcCtD
Olopatadine—Hypersensitivity—Sitagliptin—type 2 diabetes mellitus	0.000272	0.0012	CcSEcCtD
Olopatadine—Diarrhoea—Glipizide—type 2 diabetes mellitus	0.000272	0.0012	CcSEcCtD
Olopatadine—Muscle spasms—Metformin—type 2 diabetes mellitus	0.00027	0.0012	CcSEcCtD
Olopatadine—Cough—Valsartan—type 2 diabetes mellitus	0.00027	0.00119	CcSEcCtD
Olopatadine—Nausea—Rosiglitazone—type 2 diabetes mellitus	0.000269	0.00119	CcSEcCtD
Olopatadine—Nervous system disorder—Gliclazide—type 2 diabetes mellitus	0.000269	0.00119	CcSEcCtD
Olopatadine—Skin disorder—Gliclazide—type 2 diabetes mellitus	0.000267	0.00118	CcSEcCtD
Olopatadine—Conjunctivitis—Ramipril—type 2 diabetes mellitus	0.000266	0.00118	CcSEcCtD
Olopatadine—Urinary tract infection—Ramipril—type 2 diabetes mellitus	0.000266	0.00118	CcSEcCtD
Olopatadine—Cough—Orlistat—type 2 diabetes mellitus	0.000266	0.00118	CcSEcCtD
Olopatadine—Asthenia—Glimepiride—type 2 diabetes mellitus	0.000266	0.00118	CcSEcCtD
Olopatadine—Erythema—Irbesartan—type 2 diabetes mellitus	0.000265	0.00117	CcSEcCtD
Olopatadine—Vision blurred—Metformin—type 2 diabetes mellitus	0.000265	0.00117	CcSEcCtD
Olopatadine—Asthenia—Sitagliptin—type 2 diabetes mellitus	0.000265	0.00117	CcSEcCtD
Olopatadine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	0.000264	0.00117	CcSEcCtD
Olopatadine—Abdominal pain—Bromocriptine—type 2 diabetes mellitus	0.000264	0.00117	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	0.000264	0.00117	CcSEcCtD
Olopatadine—Dizziness—Glipizide—type 2 diabetes mellitus	0.000263	0.00116	CcSEcCtD
Olopatadine—Pruritus—Glimepiride—type 2 diabetes mellitus	0.000262	0.00116	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Valsartan—type 2 diabetes mellitus	0.000261	0.00116	CcSEcCtD
Olopatadine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	0.000261	0.00115	CcSEcCtD
Olopatadine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	0.00026	0.00115	CcSEcCtD
Olopatadine—Dysgeusia—Irbesartan—type 2 diabetes mellitus	0.00026	0.00115	CcSEcCtD
Olopatadine—Epistaxis—Ramipril—type 2 diabetes mellitus	0.000259	0.00114	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Orlistat—type 2 diabetes mellitus	0.000258	0.00114	CcSEcCtD
Olopatadine—Dry mouth—Valsartan—type 2 diabetes mellitus	0.000257	0.00114	CcSEcCtD
Olopatadine—Sinusitis—Ramipril—type 2 diabetes mellitus	0.000257	0.00114	CcSEcCtD
Olopatadine—Discomfort—Orlistat—type 2 diabetes mellitus	0.000257	0.00114	CcSEcCtD
Olopatadine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	0.000255	0.00113	CcSEcCtD
Olopatadine—Dry mouth—Orlistat—type 2 diabetes mellitus	0.000254	0.00112	CcSEcCtD
Olopatadine—Malaise—Metformin—type 2 diabetes mellitus	0.000254	0.00112	CcSEcCtD
Olopatadine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	0.000254	0.00112	CcSEcCtD
Olopatadine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	0.000253	0.00112	CcSEcCtD
Olopatadine—Vomiting—Glipizide—type 2 diabetes mellitus	0.000252	0.00112	CcSEcCtD
Olopatadine—Oedema—Valsartan—type 2 diabetes mellitus	0.000252	0.00112	CcSEcCtD
Olopatadine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	0.000252	0.00111	CcSEcCtD
Olopatadine—Dizziness—Pioglitazone—type 2 diabetes mellitus	0.000252	0.00111	CcSEcCtD
Olopatadine—Clomipramine—ADRA2A—type 2 diabetes mellitus	0.000251	0.0464	CrCbGaD
Olopatadine—Infection—Valsartan—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Olopatadine—Rash—Glipizide—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Olopatadine—Vision blurred—Irbesartan—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Olopatadine—Dermatitis—Glipizide—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Olopatadine—Gastrointestinal pain—Glyburide—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Olopatadine—Erythema—Losartan—type 2 diabetes mellitus	0.00025	0.00111	CcSEcCtD
Olopatadine—Oedema—Orlistat—type 2 diabetes mellitus	0.000249	0.0011	CcSEcCtD
Olopatadine—Headache—Glipizide—type 2 diabetes mellitus	0.000249	0.0011	CcSEcCtD
Olopatadine—Infection—Orlistat—type 2 diabetes mellitus	0.000247	0.0011	CcSEcCtD
Olopatadine—Nervous system disorder—Valsartan—type 2 diabetes mellitus	0.000247	0.00109	CcSEcCtD
Olopatadine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	0.000246	0.00109	CcSEcCtD
Olopatadine—Dizziness—Glimepiride—type 2 diabetes mellitus	0.000245	0.00108	CcSEcCtD
Olopatadine—Skin disorder—Valsartan—type 2 diabetes mellitus	0.000245	0.00108	CcSEcCtD
Olopatadine—Dysgeusia—Losartan—type 2 diabetes mellitus	0.000245	0.00108	CcSEcCtD
Olopatadine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	0.000245	0.00108	CcSEcCtD
Olopatadine—Nervous system disorder—Orlistat—type 2 diabetes mellitus	0.000244	0.00108	CcSEcCtD
Olopatadine—Dizziness—Sitagliptin—type 2 diabetes mellitus	0.000244	0.00108	CcSEcCtD
Olopatadine—Somnolence—Gliclazide—type 2 diabetes mellitus	0.000244	0.00108	CcSEcCtD
Olopatadine—Skin disorder—Orlistat—type 2 diabetes mellitus	0.000242	0.00107	CcSEcCtD
Olopatadine—Back pain—Losartan—type 2 diabetes mellitus	0.000242	0.00107	CcSEcCtD
Olopatadine—Abdominal pain—Glyburide—type 2 diabetes mellitus	0.000242	0.00107	CcSEcCtD
Olopatadine—Muscle spasms—Losartan—type 2 diabetes mellitus	0.00024	0.00106	CcSEcCtD
Olopatadine—Asthenia—Bromocriptine—type 2 diabetes mellitus	0.00024	0.00106	CcSEcCtD
Olopatadine—Malaise—Irbesartan—type 2 diabetes mellitus	0.000239	0.00106	CcSEcCtD
Olopatadine—Headache—Pioglitazone—type 2 diabetes mellitus	0.000238	0.00105	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Metformin—type 2 diabetes mellitus	0.000238	0.00105	CcSEcCtD
Olopatadine—Visual impairment—Ramipril—type 2 diabetes mellitus	0.000237	0.00105	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	0.000237	0.00105	CcSEcCtD
Olopatadine—Discomfort—Metformin—type 2 diabetes mellitus	0.000237	0.00105	CcSEcCtD
Olopatadine—Fatigue—Gliclazide—type 2 diabetes mellitus	0.000237	0.00105	CcSEcCtD
Olopatadine—Nausea—Glipizide—type 2 diabetes mellitus	0.000236	0.00104	CcSEcCtD
Olopatadine—Vomiting—Glimepiride—type 2 diabetes mellitus	0.000236	0.00104	CcSEcCtD
Olopatadine—Vision blurred—Losartan—type 2 diabetes mellitus	0.000235	0.00104	CcSEcCtD
Olopatadine—Vomiting—Sitagliptin—type 2 diabetes mellitus	0.000235	0.00104	CcSEcCtD
Olopatadine—Pain—Gliclazide—type 2 diabetes mellitus	0.000235	0.00104	CcSEcCtD
Olopatadine—Rash—Glimepiride—type 2 diabetes mellitus	0.000234	0.00103	CcSEcCtD
Olopatadine—Dermatitis—Glimepiride—type 2 diabetes mellitus	0.000233	0.00103	CcSEcCtD
Olopatadine—Rash—Sitagliptin—type 2 diabetes mellitus	0.000233	0.00103	CcSEcCtD
Olopatadine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	0.000233	0.00103	CcSEcCtD
Olopatadine—Headache—Glimepiride—type 2 diabetes mellitus	0.000232	0.00103	CcSEcCtD
Olopatadine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	0.000232	0.00103	CcSEcCtD
Olopatadine—Cough—Irbesartan—type 2 diabetes mellitus	0.000232	0.00103	CcSEcCtD
Olopatadine—Clomipramine—HTR2C—type 2 diabetes mellitus	0.000231	0.0428	CrCbGaD
Olopatadine—Headache—Sitagliptin—type 2 diabetes mellitus	0.000231	0.00102	CcSEcCtD
Olopatadine—Chlorprothixene—HTR2C—type 2 diabetes mellitus	0.00023	0.0426	CrCbGaD
Olopatadine—Oedema—Metformin—type 2 diabetes mellitus	0.00023	0.00102	CcSEcCtD
Olopatadine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	0.000229	0.00101	CcSEcCtD
Olopatadine—Infection—Metformin—type 2 diabetes mellitus	0.000228	0.00101	CcSEcCtD
Olopatadine—Nortriptyline—HTR2C—type 2 diabetes mellitus	0.000226	0.0418	CrCbGaD
Olopatadine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	0.000226	0.001	CcSEcCtD
Olopatadine—Malaise—Losartan—type 2 diabetes mellitus	0.000225	0.000997	CcSEcCtD
Olopatadine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	0.000225	0.000996	CcSEcCtD
Olopatadine—Nervous system disorder—Metformin—type 2 diabetes mellitus	0.000225	0.000996	CcSEcCtD
Olopatadine—Dyspnoea—Valsartan—type 2 diabetes mellitus	0.000225	0.000995	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Irbesartan—type 2 diabetes mellitus	0.000224	0.000993	CcSEcCtD
Olopatadine—Gastrointestinal pain—Gliclazide—type 2 diabetes mellitus	0.000224	0.000993	CcSEcCtD
Olopatadine—Somnolence—Valsartan—type 2 diabetes mellitus	0.000224	0.000992	CcSEcCtD
Olopatadine—Discomfort—Irbesartan—type 2 diabetes mellitus	0.000223	0.000988	CcSEcCtD
Olopatadine—Skin disorder—Metformin—type 2 diabetes mellitus	0.000223	0.000987	CcSEcCtD
Olopatadine—Immune system disorder—Ramipril—type 2 diabetes mellitus	0.000222	0.000984	CcSEcCtD
Olopatadine—Mediastinal disorder—Ramipril—type 2 diabetes mellitus	0.000222	0.000981	CcSEcCtD
Olopatadine—Dizziness—Bromocriptine—type 2 diabetes mellitus	0.000221	0.000978	CcSEcCtD
Olopatadine—Dry mouth—Irbesartan—type 2 diabetes mellitus	0.000221	0.000978	CcSEcCtD
Olopatadine—Thiothixene—CYP1A2—type 2 diabetes mellitus	0.000221	0.0408	CrCbGaD
Olopatadine—Doxepin—ADRA2A—type 2 diabetes mellitus	0.00022	0.0407	CrCbGaD
Olopatadine—Nausea—Glimepiride—type 2 diabetes mellitus	0.00022	0.000974	CcSEcCtD
Olopatadine—Cyclobenzaprine—CYP3A4—type 2 diabetes mellitus	0.00022	0.0407	CrCbGaD
Olopatadine—Nausea—Sitagliptin—type 2 diabetes mellitus	0.000219	0.000971	CcSEcCtD
Olopatadine—Asthenia—Glyburide—type 2 diabetes mellitus	0.000219	0.00097	CcSEcCtD
Olopatadine—Cough—Losartan—type 2 diabetes mellitus	0.000218	0.000965	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	0.000218	0.000963	CcSEcCtD
Olopatadine—Fatigue—Valsartan—type 2 diabetes mellitus	0.000217	0.000962	CcSEcCtD
Olopatadine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	0.000217	0.00096	CcSEcCtD
Olopatadine—Abdominal pain—Gliclazide—type 2 diabetes mellitus	0.000217	0.00096	CcSEcCtD
Olopatadine—Oedema—Irbesartan—type 2 diabetes mellitus	0.000217	0.000959	CcSEcCtD
Olopatadine—Pruritus—Glyburide—type 2 diabetes mellitus	0.000216	0.000957	CcSEcCtD
Olopatadine—Infection—Irbesartan—type 2 diabetes mellitus	0.000215	0.000952	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	0.000215	0.000952	CcSEcCtD
Olopatadine—Fatigue—Orlistat—type 2 diabetes mellitus	0.000215	0.00095	CcSEcCtD
Olopatadine—Erythema—Ramipril—type 2 diabetes mellitus	0.000214	0.000948	CcSEcCtD
Olopatadine—Pain—Orlistat—type 2 diabetes mellitus	0.000213	0.000943	CcSEcCtD
Olopatadine—Vomiting—Bromocriptine—type 2 diabetes mellitus	0.000213	0.000941	CcSEcCtD
Olopatadine—Nervous system disorder—Irbesartan—type 2 diabetes mellitus	0.000212	0.00094	CcSEcCtD
Olopatadine—Rash—Bromocriptine—type 2 diabetes mellitus	0.000211	0.000933	CcSEcCtD
Olopatadine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	0.000211	0.000932	CcSEcCtD
Olopatadine—Skin disorder—Irbesartan—type 2 diabetes mellitus	0.00021	0.000931	CcSEcCtD
Olopatadine—Discomfort—Losartan—type 2 diabetes mellitus	0.00021	0.00093	CcSEcCtD
Olopatadine—Dysgeusia—Ramipril—type 2 diabetes mellitus	0.00021	0.000928	CcSEcCtD
Olopatadine—Headache—Bromocriptine—type 2 diabetes mellitus	0.000209	0.000927	CcSEcCtD
Olopatadine—Diarrhoea—Glyburide—type 2 diabetes mellitus	0.000209	0.000925	CcSEcCtD
Olopatadine—Dry mouth—Losartan—type 2 diabetes mellitus	0.000208	0.00092	CcSEcCtD
Olopatadine—Gastrointestinal pain—Valsartan—type 2 diabetes mellitus	0.000206	0.000912	CcSEcCtD
Olopatadine—Muscle spasms—Ramipril—type 2 diabetes mellitus	0.000206	0.000911	CcSEcCtD
Olopatadine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	0.000205	0.000908	CcSEcCtD
Olopatadine—Dyspnoea—Metformin—type 2 diabetes mellitus	0.000205	0.000906	CcSEcCtD
Olopatadine—Somnolence—Metformin—type 2 diabetes mellitus	0.000204	0.000903	CcSEcCtD
Olopatadine—Oedema—Losartan—type 2 diabetes mellitus	0.000204	0.000902	CcSEcCtD
Olopatadine—Gastrointestinal pain—Orlistat—type 2 diabetes mellitus	0.000204	0.000901	CcSEcCtD
Olopatadine—Doxepin—HTR2C—type 2 diabetes mellitus	0.000203	0.0375	CrCbGaD
Olopatadine—Infection—Losartan—type 2 diabetes mellitus	0.000203	0.000896	CcSEcCtD
Olopatadine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	0.000202	0.000895	CcSEcCtD
Olopatadine—Nervous system disorder—Losartan—type 2 diabetes mellitus	0.0002	0.000885	CcSEcCtD
Olopatadine—Abdominal pain—Valsartan—type 2 diabetes mellitus	0.000199	0.000882	CcSEcCtD
Olopatadine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	0.000199	0.00088	CcSEcCtD
Olopatadine—Nausea—Bromocriptine—type 2 diabetes mellitus	0.000199	0.000879	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	0.000198	0.000877	CcSEcCtD
Olopatadine—Fatigue—Metformin—type 2 diabetes mellitus	0.000198	0.000876	CcSEcCtD
Olopatadine—Body temperature increased—Orlistat—type 2 diabetes mellitus	0.000197	0.000871	CcSEcCtD
Olopatadine—Abdominal pain—Orlistat—type 2 diabetes mellitus	0.000197	0.000871	CcSEcCtD
Olopatadine—Asthenia—Gliclazide—type 2 diabetes mellitus	0.000197	0.000871	CcSEcCtD
Olopatadine—Vomiting—Glyburide—type 2 diabetes mellitus	0.000194	0.00086	CcSEcCtD
Olopatadine—Pruritus—Gliclazide—type 2 diabetes mellitus	0.000194	0.000859	CcSEcCtD
Olopatadine—Malaise—Ramipril—type 2 diabetes mellitus	0.000193	0.000855	CcSEcCtD
Olopatadine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	0.000193	0.000855	CcSEcCtD
Olopatadine—Rash—Glyburide—type 2 diabetes mellitus	0.000193	0.000853	CcSEcCtD
Olopatadine—Somnolence—Irbesartan—type 2 diabetes mellitus	0.000193	0.000852	CcSEcCtD
Olopatadine—Dermatitis—Glyburide—type 2 diabetes mellitus	0.000192	0.000852	CcSEcCtD
Olopatadine—Headache—Glyburide—type 2 diabetes mellitus	0.000191	0.000847	CcSEcCtD
Olopatadine—Feeling abnormal—Metformin—type 2 diabetes mellitus	0.000189	0.000837	CcSEcCtD
Olopatadine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	0.000188	0.000831	CcSEcCtD
Olopatadine—Gastrointestinal pain—Metformin—type 2 diabetes mellitus	0.000188	0.000831	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	0.000187	0.000828	CcSEcCtD
Olopatadine—Cough—Ramipril—type 2 diabetes mellitus	0.000187	0.000827	CcSEcCtD
Olopatadine—Fatigue—Irbesartan—type 2 diabetes mellitus	0.000187	0.000827	CcSEcCtD
Olopatadine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	0.000186	0.000822	CcSEcCtD
Olopatadine—Pain—Irbesartan—type 2 diabetes mellitus	0.000185	0.00082	CcSEcCtD
Olopatadine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	0.000184	0.000812	CcSEcCtD
Olopatadine—Dyspnoea—Losartan—type 2 diabetes mellitus	0.000182	0.000804	CcSEcCtD
Olopatadine—Nausea—Glyburide—type 2 diabetes mellitus	0.000181	0.000803	CcSEcCtD
Olopatadine—Abdominal pain—Metformin—type 2 diabetes mellitus	0.000181	0.000803	CcSEcCtD
Olopatadine—Dizziness—Gliclazide—type 2 diabetes mellitus	0.000181	0.000803	CcSEcCtD
Olopatadine—Somnolence—Losartan—type 2 diabetes mellitus	0.000181	0.000802	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Ramipril—type 2 diabetes mellitus	0.000181	0.000801	CcSEcCtD
Olopatadine—Asthenia—Valsartan—type 2 diabetes mellitus	0.000181	0.0008	CcSEcCtD
Olopatadine—Discomfort—Ramipril—type 2 diabetes mellitus	0.00018	0.000797	CcSEcCtD
Olopatadine—Nortriptyline—CYP2E1—type 2 diabetes mellitus	0.000179	0.0331	CrCbGaD
Olopatadine—Asthenia—Orlistat—type 2 diabetes mellitus	0.000179	0.000791	CcSEcCtD
Olopatadine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	0.000179	0.00079	CcSEcCtD
Olopatadine—Pruritus—Valsartan—type 2 diabetes mellitus	0.000178	0.000789	CcSEcCtD
Olopatadine—Dry mouth—Ramipril—type 2 diabetes mellitus	0.000178	0.000789	CcSEcCtD
Olopatadine—Gastrointestinal pain—Irbesartan—type 2 diabetes mellitus	0.000177	0.000784	CcSEcCtD
Olopatadine—Pruritus—Orlistat—type 2 diabetes mellitus	0.000176	0.00078	CcSEcCtD
Olopatadine—Fatigue—Losartan—type 2 diabetes mellitus	0.000176	0.000778	CcSEcCtD
Olopatadine—Oedema—Ramipril—type 2 diabetes mellitus	0.000175	0.000774	CcSEcCtD
Olopatadine—Clomipramine—CYP1A2—type 2 diabetes mellitus	0.000175	0.0323	CrCbGaD
Olopatadine—Vomiting—Gliclazide—type 2 diabetes mellitus	0.000174	0.000772	CcSEcCtD
Olopatadine—Pain—Losartan—type 2 diabetes mellitus	0.000174	0.000772	CcSEcCtD
Olopatadine—Rash—Gliclazide—type 2 diabetes mellitus	0.000173	0.000766	CcSEcCtD
Olopatadine—Dermatitis—Gliclazide—type 2 diabetes mellitus	0.000173	0.000765	CcSEcCtD
Olopatadine—Diarrhoea—Valsartan—type 2 diabetes mellitus	0.000172	0.000763	CcSEcCtD
Olopatadine—Headache—Gliclazide—type 2 diabetes mellitus	0.000172	0.000761	CcSEcCtD
Olopatadine—Nervous system disorder—Ramipril—type 2 diabetes mellitus	0.000171	0.000759	CcSEcCtD
Olopatadine—Abdominal pain—Irbesartan—type 2 diabetes mellitus	0.000171	0.000758	CcSEcCtD
Olopatadine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	0.000171	0.000758	CcSEcCtD
Olopatadine—Nortriptyline—CYP1A2—type 2 diabetes mellitus	0.000171	0.0315	CrCbGaD
Olopatadine—Amitriptyline—ADRA2A—type 2 diabetes mellitus	0.00017	0.0315	CrCbGaD
Olopatadine—Diarrhoea—Orlistat—type 2 diabetes mellitus	0.00017	0.000754	CcSEcCtD
Olopatadine—Skin disorder—Ramipril—type 2 diabetes mellitus	0.00017	0.000751	CcSEcCtD
Olopatadine—Feeling abnormal—Losartan—type 2 diabetes mellitus	0.000168	0.000743	CcSEcCtD
Olopatadine—Gastrointestinal pain—Losartan—type 2 diabetes mellitus	0.000167	0.000738	CcSEcCtD
Olopatadine—Dizziness—Valsartan—type 2 diabetes mellitus	0.000167	0.000738	CcSEcCtD
Olopatadine—Dizziness—Orlistat—type 2 diabetes mellitus	0.000165	0.000729	CcSEcCtD
Olopatadine—Asthenia—Metformin—type 2 diabetes mellitus	0.000165	0.000729	CcSEcCtD
Olopatadine—Nausea—Gliclazide—type 2 diabetes mellitus	0.000163	0.000721	CcSEcCtD
Olopatadine—Pruritus—Metformin—type 2 diabetes mellitus	0.000162	0.000719	CcSEcCtD
Olopatadine—Body temperature increased—Losartan—type 2 diabetes mellitus	0.000161	0.000713	CcSEcCtD
Olopatadine—Abdominal pain—Losartan—type 2 diabetes mellitus	0.000161	0.000713	CcSEcCtD
Olopatadine—Vomiting—Valsartan—type 2 diabetes mellitus	0.00016	0.000709	CcSEcCtD
Olopatadine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	0.00016	0.000706	CcSEcCtD
Olopatadine—Rash—Valsartan—type 2 diabetes mellitus	0.000159	0.000703	CcSEcCtD
Olopatadine—Dermatitis—Valsartan—type 2 diabetes mellitus	0.000159	0.000703	CcSEcCtD
Olopatadine—Vomiting—Orlistat—type 2 diabetes mellitus	0.000158	0.000701	CcSEcCtD
Olopatadine—Headache—Valsartan—type 2 diabetes mellitus	0.000158	0.000699	CcSEcCtD
Olopatadine—Imipramine—HTR2C—type 2 diabetes mellitus	0.000158	0.0292	CrCbGaD
Olopatadine—Diarrhoea—Metformin—type 2 diabetes mellitus	0.000157	0.000695	CcSEcCtD
Olopatadine—Rash—Orlistat—type 2 diabetes mellitus	0.000157	0.000695	CcSEcCtD
Olopatadine—Amitriptyline—HTR2C—type 2 diabetes mellitus	0.000157	0.029	CrCbGaD
Olopatadine—Dermatitis—Orlistat—type 2 diabetes mellitus	0.000157	0.000694	CcSEcCtD
Olopatadine—Headache—Orlistat—type 2 diabetes mellitus	0.000156	0.000691	CcSEcCtD
Olopatadine—Dyspnoea—Ramipril—type 2 diabetes mellitus	0.000156	0.00069	CcSEcCtD
Olopatadine—Asthenia—Irbesartan—type 2 diabetes mellitus	0.000155	0.000688	CcSEcCtD
Olopatadine—Somnolence—Ramipril—type 2 diabetes mellitus	0.000155	0.000688	CcSEcCtD
Olopatadine—Pruritus—Irbesartan—type 2 diabetes mellitus	0.000153	0.000678	CcSEcCtD
Olopatadine—Doxepin—CYP1A2—type 2 diabetes mellitus	0.000153	0.0283	CrCbGaD
Olopatadine—Dizziness—Metformin—type 2 diabetes mellitus	0.000152	0.000672	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	0.000151	0.000668	CcSEcCtD
Olopatadine—Fatigue—Ramipril—type 2 diabetes mellitus	0.000151	0.000667	CcSEcCtD
Olopatadine—Hypersensitivity—Losartan—type 2 diabetes mellitus	0.00015	0.000665	CcSEcCtD
Olopatadine—Nausea—Valsartan—type 2 diabetes mellitus	0.00015	0.000663	CcSEcCtD
Olopatadine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	0.000148	0.000656	CcSEcCtD
Olopatadine—Nausea—Orlistat—type 2 diabetes mellitus	0.000148	0.000655	CcSEcCtD
Olopatadine—Asthenia—Losartan—type 2 diabetes mellitus	0.000146	0.000647	CcSEcCtD
Olopatadine—Vomiting—Metformin—type 2 diabetes mellitus	0.000146	0.000646	CcSEcCtD
Olopatadine—Rash—Metformin—type 2 diabetes mellitus	0.000145	0.000641	CcSEcCtD
Olopatadine—Dermatitis—Metformin—type 2 diabetes mellitus	0.000145	0.00064	CcSEcCtD
Olopatadine—Pruritus—Losartan—type 2 diabetes mellitus	0.000144	0.000638	CcSEcCtD
Olopatadine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	0.000144	0.000638	CcSEcCtD
Olopatadine—Headache—Metformin—type 2 diabetes mellitus	0.000144	0.000636	CcSEcCtD
Olopatadine—Dizziness—Irbesartan—type 2 diabetes mellitus	0.000143	0.000634	CcSEcCtD
Olopatadine—Gastrointestinal pain—Ramipril—type 2 diabetes mellitus	0.000143	0.000633	CcSEcCtD
Olopatadine—Diarrhoea—Losartan—type 2 diabetes mellitus	0.000139	0.000617	CcSEcCtD
Olopatadine—Body temperature increased—Ramipril—type 2 diabetes mellitus	0.000138	0.000612	CcSEcCtD
Olopatadine—Abdominal pain—Ramipril—type 2 diabetes mellitus	0.000138	0.000612	CcSEcCtD
Olopatadine—Vomiting—Irbesartan—type 2 diabetes mellitus	0.000138	0.00061	CcSEcCtD
Olopatadine—Rash—Irbesartan—type 2 diabetes mellitus	0.000137	0.000604	CcSEcCtD
Olopatadine—Dermatitis—Irbesartan—type 2 diabetes mellitus	0.000136	0.000604	CcSEcCtD
Olopatadine—Nausea—Metformin—type 2 diabetes mellitus	0.000136	0.000603	CcSEcCtD
Olopatadine—Headache—Irbesartan—type 2 diabetes mellitus	0.000136	0.000601	CcSEcCtD
Olopatadine—Dizziness—Losartan—type 2 diabetes mellitus	0.000135	0.000597	CcSEcCtD
Olopatadine—Acepromazine—ALB—type 2 diabetes mellitus	0.000133	0.0245	CrCbGaD
Olopatadine—Vomiting—Losartan—type 2 diabetes mellitus	0.00013	0.000574	CcSEcCtD
Olopatadine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	0.000129	0.00057	CcSEcCtD
Olopatadine—Nausea—Irbesartan—type 2 diabetes mellitus	0.000129	0.000569	CcSEcCtD
Olopatadine—Rash—Losartan—type 2 diabetes mellitus	0.000129	0.000569	CcSEcCtD
Olopatadine—Dermatitis—Losartan—type 2 diabetes mellitus	0.000128	0.000568	CcSEcCtD
Olopatadine—Headache—Losartan—type 2 diabetes mellitus	0.000128	0.000565	CcSEcCtD
Olopatadine—Thiothixene—ALB—type 2 diabetes mellitus	0.000128	0.0236	CrCbGaD
Olopatadine—Asthenia—Ramipril—type 2 diabetes mellitus	0.000125	0.000555	CcSEcCtD
Olopatadine—Imipramine—CYP2E1—type 2 diabetes mellitus	0.000125	0.0231	CrCbGaD
Olopatadine—Amitriptyline—CYP2E1—type 2 diabetes mellitus	0.000124	0.023	CrCbGaD
Olopatadine—Pruritus—Ramipril—type 2 diabetes mellitus	0.000124	0.000547	CcSEcCtD
Olopatadine—Nausea—Losartan—type 2 diabetes mellitus	0.000121	0.000536	CcSEcCtD
Olopatadine—Diarrhoea—Ramipril—type 2 diabetes mellitus	0.00012	0.000529	CcSEcCtD
Olopatadine—Imipramine—CYP1A2—type 2 diabetes mellitus	0.000119	0.022	CrCbGaD
Olopatadine—Amitriptyline—CYP1A2—type 2 diabetes mellitus	0.000118	0.0219	CrCbGaD
Olopatadine—Clomipramine—CYP3A4—type 2 diabetes mellitus	0.000116	0.0214	CrCbGaD
Olopatadine—Dizziness—Ramipril—type 2 diabetes mellitus	0.000116	0.000512	CcSEcCtD
Olopatadine—Nortriptyline—CYP3A4—type 2 diabetes mellitus	0.000113	0.0209	CrCbGaD
Olopatadine—Vomiting—Ramipril—type 2 diabetes mellitus	0.000111	0.000492	CcSEcCtD
Olopatadine—Rash—Ramipril—type 2 diabetes mellitus	0.00011	0.000488	CcSEcCtD
Olopatadine—Dermatitis—Ramipril—type 2 diabetes mellitus	0.00011	0.000487	CcSEcCtD
Olopatadine—Headache—Ramipril—type 2 diabetes mellitus	0.00011	0.000485	CcSEcCtD
Olopatadine—Nausea—Ramipril—type 2 diabetes mellitus	0.000104	0.00046	CcSEcCtD
Olopatadine—Doxepin—CYP3A4—type 2 diabetes mellitus	0.000101	0.0187	CrCbGaD
Olopatadine—Clomipramine—ALB—type 2 diabetes mellitus	0.000101	0.0186	CrCbGaD
Olopatadine—Nortriptyline—ALB—type 2 diabetes mellitus	9.85e-05	0.0182	CrCbGaD
Olopatadine—Imipramine—CYP3A4—type 2 diabetes mellitus	7.89e-05	0.0146	CrCbGaD
Olopatadine—Amitriptyline—CYP3A4—type 2 diabetes mellitus	7.84e-05	0.0145	CrCbGaD
Olopatadine—Amitriptyline—ALB—type 2 diabetes mellitus	6.84e-05	0.0126	CrCbGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CCL2—type 2 diabetes mellitus	2.88e-05	0.000235	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCR5—type 2 diabetes mellitus	2.87e-05	0.000234	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IAPP—type 2 diabetes mellitus	2.86e-05	0.000234	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CALM1—type 2 diabetes mellitus	2.84e-05	0.000232	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—LEP—type 2 diabetes mellitus	2.83e-05	0.000231	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—type 2 diabetes mellitus	2.83e-05	0.000231	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—IL6—type 2 diabetes mellitus	2.81e-05	0.000229	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—C3—type 2 diabetes mellitus	2.8e-05	0.000229	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOA1—type 2 diabetes mellitus	2.8e-05	0.000229	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—TRPC6—type 2 diabetes mellitus	2.79e-05	0.000229	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGTR2—type 2 diabetes mellitus	2.78e-05	0.000227	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NFKB1—type 2 diabetes mellitus	2.75e-05	0.000225	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT1—type 2 diabetes mellitus	2.74e-05	0.000224	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GIPR—type 2 diabetes mellitus	2.69e-05	0.00022	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GRK5—type 2 diabetes mellitus	2.69e-05	0.00022	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PRKCB—type 2 diabetes mellitus	2.67e-05	0.000218	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDNRB—type 2 diabetes mellitus	2.66e-05	0.000218	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—AGT—type 2 diabetes mellitus	2.66e-05	0.000218	CbGpPWpGaD
Olopatadine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	2.61e-05	0.000213	CbGpPWpGaD
Olopatadine—S100B—Immune System—NFKB1—type 2 diabetes mellitus	2.6e-05	0.000213	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IAPP—type 2 diabetes mellitus	2.6e-05	0.000213	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT1—type 2 diabetes mellitus	2.59e-05	0.000212	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—HTR2C—type 2 diabetes mellitus	2.58e-05	0.000211	CbGpPWpGaD
Olopatadine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	2.57e-05	0.000211	CbGpPWpGaD
Olopatadine—S100A12—Immune System—SRC—type 2 diabetes mellitus	2.57e-05	0.00021	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—TRPC6—type 2 diabetes mellitus	2.54e-05	0.000208	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IRS1—type 2 diabetes mellitus	2.52e-05	0.000207	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGTR2—type 2 diabetes mellitus	2.52e-05	0.000206	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDNRA—type 2 diabetes mellitus	2.51e-05	0.000206	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MC4R—type 2 diabetes mellitus	2.46e-05	0.000201	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADRA2A—type 2 diabetes mellitus	2.46e-05	0.000201	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GHRL—type 2 diabetes mellitus	2.45e-05	0.0002	CbGpPWpGaD
Olopatadine—S100B—Immune System—SRC—type 2 diabetes mellitus	2.43e-05	0.000198	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CALCA—type 2 diabetes mellitus	2.42e-05	0.000198	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—INS—type 2 diabetes mellitus	2.42e-05	0.000198	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDNRB—type 2 diabetes mellitus	2.42e-05	0.000198	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCL2—type 2 diabetes mellitus	2.38e-05	0.000195	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GIP—type 2 diabetes mellitus	2.37e-05	0.000194	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HTR2C—type 2 diabetes mellitus	2.35e-05	0.000192	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IGF1—type 2 diabetes mellitus	2.34e-05	0.000191	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT2—type 2 diabetes mellitus	2.34e-05	0.000191	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDNRA—type 2 diabetes mellitus	2.28e-05	0.000187	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEPR—type 2 diabetes mellitus	2.25e-05	0.000184	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGFR—type 2 diabetes mellitus	2.25e-05	0.000184	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—type 2 diabetes mellitus	2.25e-05	0.000184	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GCG—type 2 diabetes mellitus	2.24e-05	0.000183	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADRA2A—type 2 diabetes mellitus	2.23e-05	0.000183	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GHRL—type 2 diabetes mellitus	2.22e-05	0.000182	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	2.22e-05	0.000182	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—RASGRP1—type 2 diabetes mellitus	2.2e-05	0.00018	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CALCA—type 2 diabetes mellitus	2.2e-05	0.00018	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CCL2—type 2 diabetes mellitus	2.19e-05	0.000179	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ATP2A3—type 2 diabetes mellitus	2.15e-05	0.000176	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGFR—type 2 diabetes mellitus	2.13e-05	0.000174	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOS3—type 2 diabetes mellitus	2.12e-05	0.000173	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	2.12e-05	0.000173	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TLE4—type 2 diabetes mellitus	2.09e-05	0.000171	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GCG—type 2 diabetes mellitus	2.03e-05	0.000166	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRB3—type 2 diabetes mellitus	2.01e-05	0.000165	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—RASGRP1—type 2 diabetes mellitus	2e-05	0.000164	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—RELA—type 2 diabetes mellitus	2e-05	0.000163	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	1.99e-05	0.000163	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CRHR1—type 2 diabetes mellitus	1.95e-05	0.000159	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GNB3—type 2 diabetes mellitus	1.93e-05	0.000158	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AVP—type 2 diabetes mellitus	1.9e-05	0.000156	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—EDN1—type 2 diabetes mellitus	1.81e-05	0.000148	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—type 2 diabetes mellitus	1.8e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKAA1—type 2 diabetes mellitus	1.8e-05	0.000147	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MTNR1B—type 2 diabetes mellitus	1.78e-05	0.000146	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SPRY2—type 2 diabetes mellitus	1.78e-05	0.000146	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GNB3—type 2 diabetes mellitus	1.75e-05	0.000143	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	1.74e-05	0.000142	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	1.74e-05	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GLP1R—type 2 diabetes mellitus	1.73e-05	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RBP4—type 2 diabetes mellitus	1.73e-05	0.000142	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AVP—type 2 diabetes mellitus	1.73e-05	0.000141	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—MMP3—type 2 diabetes mellitus	1.73e-05	0.000141	CbGpPWpGaD
Olopatadine—S100A12—Immune System—IL6—type 2 diabetes mellitus	1.73e-05	0.000141	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—type 2 diabetes mellitus	1.73e-05	0.000141	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—ADCY5—type 2 diabetes mellitus	1.72e-05	0.000141	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCKAR—type 2 diabetes mellitus	1.71e-05	0.00014	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—type 2 diabetes mellitus	1.7e-05	0.000139	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NFKB1—type 2 diabetes mellitus	1.68e-05	0.000138	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	1.65e-05	0.000135	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	1.65e-05	0.000135	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EDN1—type 2 diabetes mellitus	1.65e-05	0.000135	CbGpPWpGaD
Olopatadine—S100B—Immune System—IL6—type 2 diabetes mellitus	1.63e-05	0.000134	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCR5—type 2 diabetes mellitus	1.62e-05	0.000132	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—type 2 diabetes mellitus	1.59e-05	0.00013	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—C3—type 2 diabetes mellitus	1.58e-05	0.000129	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	1.57e-05	0.000129	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SRC—type 2 diabetes mellitus	1.57e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—ADCY5—type 2 diabetes mellitus	1.56e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ATP2A2—type 2 diabetes mellitus	1.55e-05	0.000126	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IAPP—type 2 diabetes mellitus	1.54e-05	0.000126	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—type 2 diabetes mellitus	1.53e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INSR—type 2 diabetes mellitus	1.53e-05	0.000125	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—type 2 diabetes mellitus	1.51e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGT—type 2 diabetes mellitus	1.5e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TRPC6—type 2 diabetes mellitus	1.5e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PPP2CA—type 2 diabetes mellitus	1.5e-05	0.000123	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGTR2—type 2 diabetes mellitus	1.49e-05	0.000122	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCR5—type 2 diabetes mellitus	1.47e-05	0.00012	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	1.45e-05	0.000119	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	1.45e-05	0.000119	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—C3—type 2 diabetes mellitus	1.44e-05	0.000118	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDNRB—type 2 diabetes mellitus	1.43e-05	0.000117	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	1.4e-05	0.000115	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	1.4e-05	0.000115	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	1.4e-05	0.000115	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	1.4e-05	0.000115	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	1.4e-05	0.000115	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—type 2 diabetes mellitus	1.4e-05	0.000115	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PRKCB—type 2 diabetes mellitus	1.39e-05	0.000114	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PSMD6—type 2 diabetes mellitus	1.39e-05	0.000113	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HTR2C—type 2 diabetes mellitus	1.39e-05	0.000113	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGFR—type 2 diabetes mellitus	1.37e-05	0.000112	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGT—type 2 diabetes mellitus	1.37e-05	0.000112	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	1.36e-05	0.000111	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDNRA—type 2 diabetes mellitus	1.35e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CALM1—type 2 diabetes mellitus	1.34e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CYBA—type 2 diabetes mellitus	1.34e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADRA2A—type 2 diabetes mellitus	1.32e-05	0.000108	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PLAT—type 2 diabetes mellitus	1.31e-05	0.000107	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GHRL—type 2 diabetes mellitus	1.31e-05	0.000107	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CALCA—type 2 diabetes mellitus	1.3e-05	0.000106	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	1.28e-05	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	1.28e-05	0.000105	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRKCB—type 2 diabetes mellitus	1.26e-05	0.000103	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	1.25e-05	0.000102	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TCF7L2—type 2 diabetes mellitus	1.22e-05	0.0001	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT2—type 2 diabetes mellitus	1.22e-05	9.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GCG—type 2 diabetes mellitus	1.2e-05	9.83e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTPN1—type 2 diabetes mellitus	1.2e-05	9.83e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	1.19e-05	9.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	1.19e-05	9.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	1.19e-05	9.75e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RASGRP1—type 2 diabetes mellitus	1.18e-05	9.67e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH2—type 2 diabetes mellitus	1.18e-05	9.64e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	1.14e-05	9.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	1.14e-05	9.35e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCL2—type 2 diabetes mellitus	1.12e-05	9.2e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT2—type 2 diabetes mellitus	1.1e-05	9.04e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3R1—type 2 diabetes mellitus	1.1e-05	9.03e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	1.1e-05	9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	1.1e-05	9e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	1.08e-05	8.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	1.06e-05	8.69e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	1.06e-05	8.69e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	1.06e-05	8.69e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—IL6—type 2 diabetes mellitus	1.06e-05	8.64e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFBR2—type 2 diabetes mellitus	1.05e-05	8.55e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GNB3—type 2 diabetes mellitus	1.04e-05	8.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AVP—type 2 diabetes mellitus	1.02e-05	8.36e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP3—type 2 diabetes mellitus	1.02e-05	8.36e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF2—type 2 diabetes mellitus	1.02e-05	8.32e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CDKN2B—type 2 diabetes mellitus	1.01e-05	8.28e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3R1—type 2 diabetes mellitus	1e-05	8.2e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	9.99e-06	8.17e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOB—type 2 diabetes mellitus	9.88e-06	8.08e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1R—type 2 diabetes mellitus	9.84e-06	8.04e-05	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—type 2 diabetes mellitus	9.75e-06	7.97e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EDN1—type 2 diabetes mellitus	9.72e-06	7.95e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LPL—type 2 diabetes mellitus	9.43e-06	7.71e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	9.36e-06	7.65e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ADCY5—type 2 diabetes mellitus	9.23e-06	7.55e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	9.04e-06	7.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	9.04e-06	7.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	9.04e-06	7.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	9.04e-06	7.39e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPP2CA—type 2 diabetes mellitus	8.85e-06	7.24e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCR5—type 2 diabetes mellitus	8.69e-06	7.11e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	8.66e-06	7.09e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—C3—type 2 diabetes mellitus	8.49e-06	6.94e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HIF1A—type 2 diabetes mellitus	8.1e-06	6.62e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS2—type 2 diabetes mellitus	8.08e-06	6.61e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGT—type 2 diabetes mellitus	8.07e-06	6.6e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	8.05e-06	6.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CALM1—type 2 diabetes mellitus	7.93e-06	6.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—type 2 diabetes mellitus	7.9e-06	6.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—LEP—type 2 diabetes mellitus	7.9e-06	6.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOA1—type 2 diabetes mellitus	7.81e-06	6.39e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	7.52e-06	6.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRKCB—type 2 diabetes mellitus	7.45e-06	6.1e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	7.37e-06	6.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	7.37e-06	6.02e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	7.22e-06	5.91e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	7.18e-06	5.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	7.18e-06	5.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	7.18e-06	5.87e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	7.13e-06	5.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IRS1—type 2 diabetes mellitus	7.05e-06	5.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	7.01e-06	5.73e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	6.93e-06	5.66e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—INS—type 2 diabetes mellitus	6.75e-06	5.52e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCL2—type 2 diabetes mellitus	6.64e-06	5.43e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IGF1—type 2 diabetes mellitus	6.53e-06	5.34e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT2—type 2 diabetes mellitus	6.53e-06	5.34e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EGFR—type 2 diabetes mellitus	6.5e-06	5.32e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	6.44e-06	5.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	6.44e-06	5.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	6.44e-06	5.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	6.32e-06	5.17e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	6.26e-06	5.12e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SERPINE1—type 2 diabetes mellitus	6.2e-06	5.07e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	6.13e-06	5.01e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3R1—type 2 diabetes mellitus	5.92e-06	4.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOS3—type 2 diabetes mellitus	5.92e-06	4.84e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	5.89e-06	4.82e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	5.82e-06	4.76e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	5.82e-06	4.76e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	5.58e-06	4.57e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	5.58e-06	4.57e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—RELA—type 2 diabetes mellitus	5.57e-06	4.56e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—type 2 diabetes mellitus	5.07e-06	4.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—type 2 diabetes mellitus	5.03e-06	4.11e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IL6—type 2 diabetes mellitus	4.99e-06	4.09e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	4.81e-06	3.94e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	4.81e-06	3.94e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	4.79e-06	3.92e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—type 2 diabetes mellitus	4.75e-06	3.89e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	4.73e-06	3.87e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NFKB1—type 2 diabetes mellitus	4.7e-06	3.84e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—type 2 diabetes mellitus	4.61e-06	3.77e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	4.59e-06	3.75e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	4.46e-06	3.65e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	4.38e-06	3.58e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SRC—type 2 diabetes mellitus	4.38e-06	3.58e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	4.29e-06	3.51e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	4.27e-06	3.5e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—type 2 diabetes mellitus	4.27e-06	3.49e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	4.16e-06	3.4e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	4.11e-06	3.36e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	3.94e-06	3.23e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—type 2 diabetes mellitus	3.92e-06	3.2e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	3.87e-06	3.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGFR—type 2 diabetes mellitus	3.84e-06	3.14e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	3.75e-06	3.07e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	3.68e-06	3.01e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	3.67e-06	3e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	3.63e-06	2.97e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	3.2e-06	2.62e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	3.14e-06	2.57e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IL6—type 2 diabetes mellitus	2.95e-06	2.41e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	2.88e-06	2.35e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	2.75e-06	2.25e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	2.75e-06	2.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—type 2 diabetes mellitus	2.72e-06	2.23e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	2.52e-06	2.06e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	1.26e-06	1.03e-05	CbGpPWpGaD
